William Aliski

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Novato, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Adam S. Mostafa, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for William Aliski

Form 4 holding Director

X4 Pharmaceuticals, Inc

Security class
Common Stock
Shares / value
96,667
Estimated value
$85,241
Report date
10 Jun 2024
Price
$0.8818
Ownership
Direct
Form 4 holding Director

Ultragenyx Pharmaceutical Inc.

Security class
Stock Option (Right to Buy)
Shares / value
4,125
Estimated value
Report date
24 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

APPLIED GENETIC TECHNOLOGIES CORP

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
30 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William Aliski

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .